MW Pariza , Y Park & ME Cook (1999) Conjugated linoleic acid and the control of cancer and obesity. Toxicol Sci 52, 107–110.
M Pariza , S Ashoor , F Chu & D Lund (1979) Effects of temperature and time on mutagen formation in pan-fried hamburger. Cancer Lett 7, 63–69.
HX Zu & HA Schut (1992) Inhibition of 2-amino-3-methylimidazol (4,5-f) quinoline-DNA adduct formation in CDF1 mice by heat-altered derivatives of linoleic acid. Food Chem Toxicol 30, 9–16.
C Liew , HA Schut , SF Chin , MW Pariza & RH Dashwood (1995) Protection of conjugated linoleic acids against 2-amino-3-methylimidazol (4,5-f) quinoline-induced colon carcinogenesis in the F344 rat: a study of inhibitory mechanisms. Carcinogenesis 16, 3037–3043.
KN Lee , D Kritchevsky & MW Pariza (1994) Conjugated linoleic acid and atherosclerosis in rabbits. Atherosclerosis 108, 19–25.
C Miller , Y Park , MW Pariza & M Cook (1994) Feeding conjugated linoleic acid to animals partially overcomes catabolic responses due to endotoxin injection. Biochem Biophys Res Commun 198, 1107–1112.
Y Park , KJ Allbright , W Liu , JM Storkson , ME Cooj & MW Pariza (1997) Effects of conjugated linoleic acid on body composition in mice. Lipids 32, 853–858.
JB German , CJ Dilard & RE Ward (2002) Bioactive components in milk. Curr Opin Clin Nutr Metab Care 5, 653–658.
L Yu , D Adams & BA Watkins (2003) Comparison of commercial supplements containing conjugated linoleic acids. J Food Composit Anal 16, 419–428.
K Nagao & T Yanagita (2005) Conjugated fatty acids in food and their health benefits. J Biosci Bioeng 100, 152–157.
JM Gaullier , G Berven , H Blankson & O Gudmundsen (2002) Clinical trial results support a preference for using CLA preparations enriched with two isomers rather than four isomers in human studies. Lipids 37, 1019–1025.
A Smedman & B Vessby (2001) Conjugated linoleic acid supplementation in humans – metabolic effects. Lipids 36, 773–781.
E Thom , J Wadstein & O Gudmunsen (2001) Conjugated linoleic acid reduces body fat in healthy exercising humans. J Int Med Res 29, 392–396.
U Riserús , P Arner , K Brismar & B Vessby (2002) Treatment with dietary trans-10 cis-12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with metabolic syndrome. Diabetes Care 25, 1516–1521.
G Berven , A Bye , O Hals & OA Karlsen (2000) Safety of conjugated linoleic acid (CLA) in overweight or obese human volunteers. Eur J Lipid Sci Technol 102, 455–462.
KL Zambell , NL Keim , MD Van Loan , B Gale , P Benito , DS Kelley & GJ Nelson (2000) Conjugated linoleic acid supplementation in humans: effects on body composition and energy expenditure. Lipids 35, 777–782.
U Riserús , L Berglund & B Vessby (2001) Conjugated linoleic acid (CLA) reduced abdominal adipose tissue in obese middle-aged men with signs of metabolic syndrome: a randomised controlled trial. Int J Obes Relat Metab Disord 25, 1129–1135.
MM Kamphuis , MP Lejeune , WH Saris & MS Westerterp-Plantenga (2003) The effect of conjugated linoleic acid supplementation after weight loss on body weight regain, body composition, and resting metabolic rate in overweight subjects. Int J Obes Relat Metab Disord 27, 840–847.
C Malpuech-Brugere , WP Verboeket-van de Venne , RP Mensink , MA Arnal , B Morio , M Brandolini , A Saebo , TS Lassel , JM Chardigny , JL Sebedio & B Beaufrere (2004) Effects of two conjugated linoleic acid isomers on body fat mass in overweight humans. Obes Res 12, 591–598.
CL Craig , Al Marshall , M Sjostrom , AE Bauman , ML Booth , BE Ainsworth , M Pratt , U Ekelund , A Yngve , JF Sallis & P Oja (2003) International Physical Activity Questionnaire (IPAQ): 12-country reliability and validity. Med Sci Sports Exer 35, 1381–1395.
MW Pariza , Y Park & ME Cook (2001) The biologically active isomers of conjugated linoleic acid. Prog Lipid Res 40, 283–298.
Y Park , JM Storckson , KJ Albright , W Liu & MW Pariza (1999) Evidence that the trans-10,cis-12 isomers of conjugated linoleic acid induces body composition changes in mice. Lipids 34, 235–241.
M Evans , C Geigerman , J Cook , L Curtis , B Kuebler & M McIntosh (2000) Conjugated acid linoleic suppresses triglyceride accumulation and induces apoptosis in 3T3-L1 preadipocytes. Lipids 35, 899–910.
Y Park & MW Pariza (2001) The effects of dietary conjugated nonadecadienoic acid and body composition in mice. Biochim Biophys Acta 1533, 171–174.
C Kallen & M Lazar (1996) Antidiabetic thiazolidinediones inhibit leptin on gene expression in 3T3-L1 adipocytes. Proc Natl Acad Sci USA 93, 5793–5796.
L Granlud , L Juvet , J Pedersen & H Nebb (2003) Trans 10, cis 12-conjugated linoleic acid prevents triacylglycerol accumulation in adipocytes by acting as a PPARgamma modulator. J Lipid Res 44, 1441–1452.
B Szymczyk , PM Pisulewski , W Szczurek & P Hanczakowski (2001) Effects of conjugated linoleic acid on growth performance, feed conversion efficiency, and subsequent carcass quality in broiler chickens. Br J Nutr 85, 465–473.
J Salas-Salvado , F Marquez-Sandoval & M Bullo (2006) Conjugated linoleic acid intake in humans: a systematic review focusing on its effect on body composition, glucose, and lipid metabolism. Crit Rev Food Sci Nutr 46, 479–488.
EJ Noone , HM Roche , AP Nugent & MJ Gibney (2002) The effect of dietary supplementation using isomeric blends of conjugated linoleic acid on lipid metabolism in healthy human subjects. Br J Nutr 88, 243–251.
S Basu , U Riserús , A Turpeinen & B Vessby (2000) Conjugated linoleic acid induces lipid peroxidation in men with abdominal obesity. Clin Sci 99, 511–516.
S Basu , A Smedman & B Vessby (2000) Conjugated linoleic acid induces lipid peroxidation in humans. FEBS Lett 468, 33–36.
N Tsuboyama-Kasaoka , M Takahashi , K Tanemura , HJ Kim , T Tange , H Okuyama , M Kasai , S Ikemoto & O Ezaki (2000) Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes 49, 1534–1542.